Imax Q1 lifts on Project Hail Mary gains: still behind last year’s Ne Zha 2 windfall

IMAX reported a first-quarter beat that underscored the box office power of a handful of big releases even as overall revenue dipped. The company outperformed analysts’ expectations on both earnings and profit per share, and reiterated ambitious box-office targets for 2026.

Revenue for the quarter fell compared with a year earlier, but stronger ticket sales in North America and other markets helped lift profitability and gave management confidence to maintain its full-year outlook.

What the quarter showed

IMAX posted total revenue of $81.4 million, a decline of about 6% from the same period last year, while adjusted earnings rose to $0.17 per share from $0.13 a year earlier. Both figures surpassed Wall Street forecasts, a result the company attributed in large part to the success of one headline title.

  • Top performer: Amazon MGM Studios’ Project Hail Mary — starring Ryan Gosling — significantly outpaced IMAX’s internal expectations, pulling in more than $600 million worldwide to date and lifting ticket sales during the quarter.
  • Quarter box office: IMAX venues generated roughly $260 million globally in the period, led by Project Hail Mary and Avatar: The Last Airbender — Fire and Ash.
  • Regional mix: China lagged the year-ago quarter — which benefited from the extraordinary run of Ne Zha 2 — while North America grew about 75% and other international markets (excluding China) rose about 60% year over year.
  • Guidance: IMAX reaffirmed its plan to deliver a record $1.4 billion in global box-office receipts at its sites in 2026.

The comparison with last year is sharp: Ne Zha 2 was a runaway hit during the Chinese New Year window, amassing more than $2.2 billion and creating a tough year-over-year benchmark for exhibitors this quarter. That explains much of the overall revenue shortfall even as other regions posted robust gains.

For investors and industry observers, the takeaway is twofold. First, tentpole films with broad international appeal can materially boost IMAX’s results even when one major market softens. Second, the company’s reaffirmed 2026 target signals confidence in its pipeline and in the continued value of premium large-format exhibition.

Leadership update

CEO Rich Gelfond has been slowly resuming his responsibilities after a brief medical leave related to pneumonia. He told the company he’s recovering, has been discharged from the hospital, and will continue to focus on his health in the coming weeks. Gelfond’s limited visibility at recent industry events had prompted questions about leadership continuity; his return should reassure partners and investors alike.

Why this matters now

The quarter highlights how box-office fortunes remain tied to a small number of blockbuster releases and regional timing. As studios schedule major films and China’s market continues to fluctuate, exhibitors such as IMAX will likely see quarters of wide variance — but the company’s ability to beat expectations and hold its long-term target suggests resilience in the premium exhibition model.

Similar Posts

Rate this post
Read also  Under Paris 2 starts production: Netflix shark sequel rolls cameras

Leave a Comment

Share to...